不规则抗体筛检在围产期孕妇产前检查中的临床应用  

Clinical Application of Irregular Antibody Screening in Prenatal Screening of Pregnant Women

作　　者：武春梅 

机构地区：[1]商丘市妇幼保健院妇科,河南商丘476000

出　　处：《中国卫生标准管理》2016年第22期154-155,共2页China Health Standard Management

摘　　要：目的探讨对围产期孕妇在实施产前检查过程中,不规则抗体筛检的临床实施价值。方法选择我院2014年5月-2016年2月收治的围产期孕妇162例作为研究对象,依据是否接受不规则抗体筛检展开临床分组;观察组（81例）临床实施不规则抗体筛检;对照组（81例）临床未实施不规则抗体筛检,对比新生儿溶血发生率等。结果在新生儿溶血发生率方面,两组产妇对比差异有统计学意义（P〈0.05）;在血清总胆红素浓度方面,两组产妇对比差异有统计学意义（P〈0.05）。结论对于围产期孕妇,临床积极开展不规则抗体筛检,可有效降低患者出现新生儿溶血的概率,充分保障母婴健康。Objective To investigate the clinical value of irregular antibody screening in the prenatal examination for pregnant women. Methods In our hospital from May 2014 to February 2016,162 cases of perinatal pregnant women as the research object,on the basis of whether or not to accept the irregular antibody screening clinical groups,observation group（81 cases）was in the implementation of irregular antibody screening,control group（81 cases）without clinical implementation of irregular antibody screening,comparison of neonatal hemolytic probability etc. Results The probability of appearing in hemolytic disease of newborn,comparison between the two groups,the difference was statistically significant（P〈0.05）,the serum total bilirubin concentration,the contrast between the two groups,the difference was statistically significant（P〈0.05）. Conclusion For pregnant women during the perinatal period,and actively carry out clinical irregular antibody screening,can effectively reduce the probability of occurrence in patients with hemolytic disease of the newborn,and fully protect the health of mother and infant.

关 键 词：不规则抗体筛检 围产期孕妇 产前检查 

分 类 号：R715[医药卫生—妇产科学]